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Abstract
Motivation: A major cause of autosomal dominant disease is haploinsufficiency, whereby a single
copy of a gene is not sufficient to maintain the normal function of the gene. A large proportion of
existing methods for predicting haploinsufficiency incorporate biological networks, e.g. protein-
protein interaction networks that have recently been shown to introduce study bias. As a result,
these methods tend to perform best on well-studied genes, but underperform on less studied
genes. The advent of large genome sequencing consortia, such as the 1000 genomes project,
NHLBI Exome Sequencing Project and the Exome Aggregation Consortium creates an urgent need
for unbiased haploinsufficiency prediction methods.
Results: Here, we describe a machine learning approach, called HIPred, that integrates genomic
and evolutionary information from ENSEMBL, with functional annotations from the Encyclopaedia
of DNA Elements consortium and the NIH Roadmap Epigenomics Project to predict haploinsuffi-
ciency, without the study bias described earlier. We benchmark HIPred using several datasets and
show that our unbiased method performs as well as, and in most cases, outperforms existing
biased algorithms.
Availability and Implementation: HIPred scores for all gene identifiers are available at: https://
github.com/HAShihab/HIPred.
Contact: h.shihab@bristol.ac.uk or tom.gaunt@bristol.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Technological advances and the falling costs of next-generation
sequencing technologies have accelerated the identification of gen-
etic variation in the human genome (The 1000 Genomes Project
Consortium, 2012). The most common form of genetic variation is
single nucleotide variants (SNVs) and small insertions/deletions
(INDELs). Identifying which of these are functional promises to
improve our understanding of the molecular mechanisms of human
disease and lead to novel treatments. As a result, there is a plethora
of in silico algorithms capable of predicting the functional impact
of SNVs and INDELs, e.g. (Choi et al., 2012; Kircher et al., 2014;
Ritchie et al., 2014; Shihab et al., 2013, 2015). On the other hand,
loss-of-function (LoF) variants, i.e. truncating mutations and
whole gene deletions, have traditionally been considered to be rare
and highly deleterious. However, there is growing evidence to sug-
gest that LoF variants are common amongst healthy individuals
(MacArthur et al., 2012; Ng et al., 2008; Pelak et al., 2010).
Haploinsufficiency, whereby a single copy of a gene product is not
sufficient to maintain the normal function of the gene, is just one
possible biological mechanism implicating LoF variants to abnor-
mal phenotypes (Veitia and Birchler, 2010). Prediction of haploin-
sufficiency is an important aspect to interpreting whole genome
sequence data, in which each individual will have a number of non-
sense and missense mutations. Therefore, accurate methods for
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identifying haploinsufficiency within the genome are of increasing
importance.
A large proportion of the existing algorithms for predicting hap-
loinsufficiency utilize biological networks, such as protein–protein
interaction networks. However, it has been shown that commonly
used biological networks are heavily affected by study bias
(Steinberg et al., 2015); i.e. well studied genes are over-represented
with respect to the number of networks they are part of and the
number of links they form within these networks. As a result, these
methods tend to perform best on well-studied genes but underper-
form on less studied genes. Steinberg et al. (2015) constructed an un-
biased genome-wide haploinsufficiency score (GHIS) by replacing
these biological networks with co-expression networks. However,
other potentially informative sources for functional annotation in-
clude the Encyclopaedia of DNA Elements (ENCODE) consortium
(The ENCODE Project Consortium, 2012) and the NIH Roadmap
Epigenomics Project (Roadmap Epigenomics Consortium et al.,
2015). Following our previous work (Shihab et al., 2015), we de-
scribe a machine learning approach (called HIPred) that integrates
genomic and evolutionary features with functional annotations from
ENCODE and NIH Roadmap Epigenomics to predict haploinsuffi-
ciency. We observe improved performance when compared with five
existing methods, but without the potential study bias described
earlier. Pre-computed HIPred scores for all gene identifiers
(GRCh37) are available at: https://github.com/HAShihab/HIPred.
2 Materials and methods
2.1 Datasets
We assembled two datasets for training: our positive dataset was
constructed using 299 known haploinsufficient genes from (Dang
et al., 2008) and our negative dataset was constructed using 386 pu-
tative loss-of-function tolerant (LoFT) genes from (MacArthur
et al., 2012). After removing records with conflicting annotations
and ambiguous mappings, we retained 298 haploinsufficient and
386 LoFT genes.
Following a similar procedure described in Steinberg et al.
(2015), we used the following benchmarks from (Petrovski et al.,
2013) to evaluate the performance of HIPred: 175 genes listed as
haploinsufficient in OMIM (OMIM HI), 108 genes listed as hap-
loinsufficient with known de novo mutations in OMIM (OMIM HI
de novo), 91 genes for which a heterozygous gene knockout causes
‘lethality’ phenotypes in mouse (MGI Lethality) and 95 genes for
which a heterozygous gene knockout causes seizures in mouse (MGI
Seizures). Next, we collected a list of 59 genes disrupted by de novo
LoF mutations in autism probands (ASD1) (Iossifov et al., 2012)
and a further 64 genes disrupted by de novo LoF mutations in other
sets of autism probands (ASD2). (Neale et al., 2012; O’Roak et al.,
2012; Sanders et al., 2012). The composition of haploinsufficient
genes across these benchmarks, and their overlap with our training
data, is summarized in Supplementary Table S1. The actual genes
used in these benchmarks are given as Supplementary Material.
Finally, for each gene, we also obtained the number of associated
publications in PubMed using the NCBI Entrez Search and Retrieval
System and used this as a measure of how ‘well-studied’ these genes
are.
2.2 Feature groups
Following our previous work (Shihab et al., 2015), we annotated
our datasets using a number of feature groups, which could be pre-
dictive of haploinsufficiency. A detailed description of these feature
groups can be found in Supplementary Table S2, but a short descrip-
tion is as follows:
• Genomic and evolutionary: we used a number of genomic prop-
erties such as the length of the gene, number of transcripts and
the average number of predicted protein domains across tran-
scripts. A comprehensive set of conservation-based measures,
such as dN/dS ratios between human and 65 different species
(one-to-one orthologues), was also used. In addition, we also
tested whether the number of observed rare variants (MAF <
0.01) from the Exome Aggregation Consortium (ExAC) (Lek
et al., 2016), the number of expected rare variants across the
gene, and a z-score representing the deviation of observed from
expected added any predictive value.
• Histone modifications: we used regions of enrichment based on
histone ChIP-seq peak calls from ENCODE and NIH Roadmap
Epigenomics.
• Open chromatin: we used regions of enrichment based on
DNase-seq and Formaldehyde-Assisted Isolation of Regulatory
Elements peak calls from ENCODE and NIH Roadmap
Epigenomics.
• Transcription factor-binding sites: based on PeakSeq and SPP
peak calls for 119 transcription factors across 77 cell lines from
ENCODE.
• Gene expression: based on RNA-seq signal coverage using con-
solidated epigenomes from NIH Roadmap Epigenomics.
• Methylation: based on whole genome bisulphite sequencing from
NIH Roadmap Epigenomics.
• Digital genomic footprinting sites: for transcription factor recog-
nition sequences within DNase-hypersensitive sites using consoli-
dated epigenomes from the NIH Roadmap Epigenomics Project.
• Networks: we used measures of centrality from cell-type specific
interactome and tissue-specific co-expression networks.
As described in the Supplementary Material, the majority of our
feature groups comprise multiple annotations across a gene. For ex-
ample, there could be multiple ChIP-seq values across a given region
(one value for each position). In these instances, we used the median
value across the region. We also tested other summary measures,
specifically the mean and maximum value across a region; however,
these summaries did not yield any significant improvements in the
overall performance of our method (data not shown).
2.3 Data integration
The resulting product of our data preparation is several large matri-
ces comprising data from the above feature groups, each of which
can have different measurement scales. Therefore, we investigated
three approaches for data integration (see Fig. 1). First, we evaluated
data integration at the data level (i.e. concatenating datasets into a
single matrix). This form of data integration is the simplest and
most intuitive; however, combining feature groups in this way cre-
ates additional analytical challenges. For example, classifiers will
need to handle a larger number of heterogeneous features.
Therefore, we used a gradient boosted machine (Chen and Guestrin,
2016) as they can handle heterogeneous datasets, are robust to miss-
ing data and can estimate the relative importance of features. To il-
lustrate the potential benefits of using a gradient boosted machine
on this type of data, as opposed to alternative machine learning al-
gorithms, we also evaluated the performance of a support vector
machine (SVM) (Campbell and Ying, 2011) on the same task.
Next, we evaluated data integration based on multiple kernel
learning (MKL). In MKL, feature groups are encoded into a
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corresponding base kernel K‘ (where ‘ ¼ 1; . . . ;p if there are p fea-
ture groups), from which we can derive a composite kernel matrix
K ¼Pp‘¼1 k‘K‘. This composite kernel can then be used with a
kernel-based classifier such as the SVM, which was the classifier
used here. The k‘ are kernel weights where
Pp
‘¼1 k‘ ¼ 1 and k‘  0.
These weights can be adjusted according to the relative informative-
ness of the different feature groups. We used an L1-norm to yield
sparse solutions that implicitly excludes uninformative feature
groups by assigning them zero weight.
Finally, we evaluated data integration based on stacking. Here,
each feature group was tested against a number of machine learning
algorithms, e.g. naı¨ve Bayes, SVMs and random forests, and the best
performing algorithm was chosen as the base classifier for the group
C‘ (where ‘ ¼ 1; . . . ; p if there are p feature groups). These base clas-
sifiers were then ’stacked’ (i.e. combined) using a logistic regression:
log p1p
 
¼Ppi¼1 biCi þ a, where the bi of each base classifier was
deduced through the regression process. As with MKL, we used an
L1-norm to implicitly exclude uninformative feature groups by as-
signing them zero coefficient.
We present our results using several performance statistics, such
as the overall accuracy, sensitivity and specificity. In addition, we
provide receiver operating characteristic (ROC) curves and area
under the curve (AUC) statistics. Individual algorithm parameters,
e.g. the SVM cost parameter C, were optimized through a 10-fold
cross-validation and grid search.
To remove the potential bias caused by the random partitioning
of the datasets during cross validation, we repeated our analysis 30
times and report the mean values and SDs above 0.01. In order to al-
leviate any performance artifacts arising from potential gene similar-
ity within our training dataset, we performed a gene similarity
analysis using NCBI’s BLASTCLUST algorithm using the following
parameters: -p F, -L 0.6, -b F and -S 10.
Finally, we performed a feature selection analysis to identify im-
portant features and improve model interpretation. All analyses in
this study were performed using scikit-learn (Pedregosa et al., 2011),
SHOGUN (Sonnenburg et al., 2010) and xgboost (Chen and
Guestrin, 2016).
2.4 Sequential learning
Both MKL and stacking rely on the assumption that data are avail-
able in every feature group for every training example. However, in
practice, data can be absent from some feature groups, e.g. not every
position in the genome will have annotations for Open Chromatin.
We could use all available feature groups, but this would result in
fewer training examples. With all values present for all feature
groups, our training dataset consisted 156 haploinsufficient genes
and just 52 LoFT genes. On the other hand, we could use a smaller
number of feature groups, but with many more training examples.
Therefore, we opted for an iterative sequential learning approach to
determine the best combination of base kernels (MKL) and classi-
fiers (stacking) (Rogers et al., 2015). Here, we rank the base kernels/
classifiers based on their individual cross-validation performance.
Then, starting with the best performing base kernel/classifier, we it-
eratively add feature groups and retest the combined model using
the same cross-validation procedure. If performance improves, then
the feature group is added to the final model and the process is re-
peated until no more feature groups can be added.
2.5 Comparison with existing methods
For each of the benchmarks described in Datasets, we compared
HIPred with 5 alternative methods that could be used to predict hap-
loinsufficiency: predicted haploinsufficiency probabilities, HIS and
HIS Imputed (Huang et al., 2010); predicted gene indispensability
scores (IS) (Khurana et al., 2013); Residual Variance Intolerance
Scores (RVIS) (Petrovski et al., 2013); Evolutionary Intolerance
(EvoTol) (Rackham et al., 2014); and predicted genome-wide hap-
loinsufficiency probabilities (GHIS) (Steinberg et al., 2015). In add-
ition, we evaluated the correlation between each of the methods
evaluated based on the absolute Spearmando rank correlation
coefficient.
3 Results
3.1 Performance of the method
On our training dataset, the performance of existing methods
ranged from 0.6929 to 0.8549, with the HIS (Imputed) probabilities
achieving the highest AUC (see Table 1). However, due to potential
overlaps between this dataset and the datasets used to train these al-
gorithms, the performances reported here may be over-inflated and
may not represent the true generalizability of existing methods (see
section 3.2 below).
Next, we evaluated the performance of a gradient boosted ma-
chine, i.e. data integration at the data level. In terms of AUC, the
performance of our gradient boosted machine outperformed all
existing methods with an average AUC of 0.8940. Comparing the
performance of a gradient boosted machine and SVMs, we achieved
a nominal AUC of 0.8133 using SVMs; thereby highlighting the
Fig. 1. Methods for integrating feature groups: (a) feature groups are combined at the data level and fed into a single classifier; (b) feature groups are encoded as
base kernels and combined using MKL; and (c) feature groups are used to construct heterogeneous base classifiers which are then combined using a stacking
approach
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potential pitfalls of integrating large heterogeneous datasets at the
data level.
In our experiments, the highest performing MKL model com-
prised seven feature groups and achieved an average AUC of
0.8747. Here, Genomic and Evolutionary was the highest perform-
ing individual feature group with an average AUC of 0.8179, fol-
lowed by Open Chromatin and Histone Modifications from the
NIH Roadmap Epigenomics Project (i.e. gappedPeak and
narrowPeak) with an average AUC of 0.8103 and 0.8035, respect-
ively. Histone Modifications from ENCODE yielded an average
AUC of 0.7518. We observed a performance boost of 4.61% during
the first stage of our sequential learning approach. However, we
observed minor improvements at each subsequent iteration.
Interestingly, MKL assigned the largest weight to Histone
Modifications from ENCODE (0.6056), whose individual perform-
ance was ranked 4th overall, followed by Genomic and
Evolutionary (0.2233) and Open Chromatin/Histone Modifications
(narrowPeak) from NIH Roadmap Epigenomes Project (0.1701). A
lower weight was assigned to gappedPeak and broadPeak (0.0008
and 0.0001, respectively), probably because of the similarities be-
tween these feature groups and the narrowPeak feature group (see
Supplementary Tables S3 and S4).
The best performing stacked model comprised four feature
groups and had an average AUC of 0.8866. As with MKL, Genomic
and Evolutionary was the best performing feature group with an
average AUC of 0.8196, followed by Open Chromatin and Histone
Modifications (narrowPeak) with an AUC of 0.8794. However, in
contrast to MKL, we observed a small performance boost of 0.38%
after the initial sequential learning iteration. In our experiments, the
most informative feature group was Genomic and Evolutionary
with a regression coefficient of 4.0810, followed by Gene
Expression and Open Chromatin (regression coefficients 2.1805 and
2.1391, respectively). Despite the best performing model comprising
four feature groups during cross-validation, the final logistic regres-
sion assigned zero coefficients to one of these feature groups (see
Supplementary Tables S5 and S6).
From our analysis, it would appear that all 3 data integration
classifiers evaluated outperform existing methods, with a classifier
based on integration at the data level performing best. However, the
difference in performance between these three data integration tech-
niques evaluated is marginal. Nonetheless, for maximum perform-
ance and improved model interpretation, the final version of HIPred
is based on a gradient boosted machine. All subsequent analyses pre-
sented are based on this version.
Next, we tested for potential gene similarity (at the nucleotide
level) within our training data using the NCBI BLASTCLUST algo-
rithm. Using a minimum sequence identity and sequence coverage of
60%, we did not find any gene clusters.
Finally, we performed a feature selection analysis to identify the
most informative features (see Fig. 2). The most important feature
identified from this analysis was the ExAC (E) missense z-scores for
the deviation of observed missense variants from expectation (gain
¼ 0.34), followed by several cell-type specific interactomes (I), such
as the Mesenchymal Precursor (gain ¼ 0.09), and genomic/evolu-
tionary features (G), such as the dN/dS ratios and percent identity
with other Ensembl genomes. We also assessed the performance of
our final model using a progressive number of features and found
that a maximum tree depth of 2 yields optimal performance (see
Supplementary Material).
3.2 Performance using known and candidate disease
genes
We evaluated HIPred on a set of known human disease-associated genes
and mouse model equivalents. After removing genes that were present
in our training data (see Supplementary Table S1), we were left with 81
OMIM HI and 49 OMIM HI de novo genes. Following the procedure
described in Steinberg et al. (2015), we matched these genes to an equal
number of random genes based on gene length, which were assumed to
be neutral. In general, HIPred outperformed the RVIS, EvoTol and
GHIS across both OMIM datasets (see Table 2). Furthermore, HIPred
marginally outperformed the HIS (both imputed and non-imputed) and
Indispensability probabilities. However, these OMIM datasets comprise
some of the most studied genes which could artificially inflate the
observed performances of biased predictors. ROC curves are made
available as Supplementary Figure S1.
Next, we tested these methods using a set of genes for which a
heterozygous gene knockout causes ‘lethality’ phenotypes and seiz-
ures in mouse. After removing genes that were also present in our
training data, we were left with 75 MGI Lethality and 90 MGI
Seizure genes, which were matched using the same procedure as
above. From our analysis, it would appear that HIPred outperforms
all other methods across these datasets. Although the performance
Table 1. Performance of haploinsufficiency predictors on our training data
Method Accuracy Sensitivity Specificity Precision NPV AUC
EvoTol 0.6367 0.5577 0.7988 0.6905 0.6917 0.6929
GHIS 0.7069 0.7178 0.6327 0.6578 0.6951 0.7450
RVIS 0.8129 0.7895 0.7596 0.7059 0.8316 0.8329
HIS 0.6707 0.6683 0.8383 0.8354 0.6731 0.8412
IS 0.8478 0.8403 0.7017 0.6779 0.8547 0.8489
HIS (Imputed) 0.6195 0.5155 0.9257 0.8581 0.6867 0.8549
HIPreda 0.9032 0.8846 0.8919 0.8519 0.9167 0.8940
Note: NPV, negative predictive value; AUC, area under the curve.
aThe reported performance of HIPred is the average performance observed across our repeated cross-validation procedure.
Fig. 2. Informative features used for predicting haploinsufficient genes
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of HIPred appears to drop on the MGI Seizures datasets, the drop in
performance is not as drastic as that observed with other methods.
Using the number of associated publications in PubMed as a
proxy of how well genes are studied, we tested whether the MGI
dataset was enriched for less-studied genes compared with the
OMIM datasets. Although the median number of publications was
lower in the MGI datasets, we did not reach statistical significance
using a Mann-Whitney U-test (P ¼ 0.13 for MGI Seizures versus
OMIM HI and P ¼ 0.34 for MGI Lethality versus OMIM HI).
Therefore, we also tested these methods on a set of candidate disease
genes linked to autism (ASD1 and ASD2). These datasets were
statistically enriched for less studied genes than the OMIM datasets
(P ¼ 0.02 for ASD1 versus OMIM HI and P ¼ 0.01 ASD2 versus
OMIM HI). After removing genes that were also present in our
training data, we matched the remaining genes to to a random set of
genes based on gene length as above. Our analysis shows that the
performance of all methods drops significantly on these datasets,
with RVIS performing best. The performance of HIPred is compar-
able to GHIS across the ASD datasets. However, it should be noted
that we cannot be sure which ASD genes are casual (Steinberg et al.,
2015). Therefore, the results of this benchmark should be inter-
preted with some caution.
Table 2. Performance of methods used for predicting haploinsufficiency on known disease genes and mouse models
Method Accuracy Sensitivity Specificity Precision NPV AUC
OMIM HI
EvoTol 0.5232 0.5263 0.7358 0.7407 0.5200 0.6477
GHIS 0.8077 0.8630 0.3621 0.6300 0.6774 0.6845
RVIS 0.7593 0.8354 0.2807 0.6168 0.5517 0.6609
HIS 0.6604 0.7049 0.6923 0.7818 0.6000 0.7303
IS 0.7869 0.8354 0.5172 0.7021 0.6977 0.7451
HIS (Imputed) 0.4933 0.4722 0.8333 0.8095 0.5128 0.7156
HIPred 0.7606 0.7821 0.6026 0.6630 0.7344 0.7543
OMIM HI de novo
EvoTol 0.5455 0.5455 0.7273 0.7273 0.5455 0.6959
GHIS 0.8361 0.8889 0.2973 0.6061 0.6875 0.7135
RVIS 0.8667 0.9149 0.2500 0.6143 0.6923 0.6965
HIS 0.7188 0.7568 0.6923 0.7778 0.6667 0.7599
IS 0.8286 0.8723 0.4857 0.6949 0.7391 0.7350
HIS (Imputed) 0.5455 0.5349 0.8333 0.8214 0.5556 0.7357
HIPred 0.8919 0.9130 0.5217 0.6562 0.8571 0.7902
MGI lethality
EvoTol 0.4928 0.5000 0.7174 0.7292 0.4853 0.6258
GHIS 0.7576 0.8235 0.3958 0.6588 0.6129 0.6725
RVIS 0.6697 0.7600 0.3636 0.6706 0.4706 0.6523
HIS 0.5600 0.5926 0.7742 0.8205 0.5217 0.7210
IS 0.6949 0.7568 0.5200 0.7000 0.5909 0.7065
HIS (Imputed) 0.4676 0.4478 0.8537 0.8333 0.4861 0.7632
HIPred 0.7872 0.7973 0.7027 0.7284 0.7761 0.8143
MGI seizures
EvoTol 0.5341 0.5287 0.7164 0.7077 0.5393 0.6611
GHIS 0.6748 0.7619 0.2879 0.5766 0.4872 0.5826
RVIS 0.7440 0.8222 0.2836 0.6066 0.5429 0.5748
HIS 0.4759 0.5000 0.6327 0.6786 0.4493 0.5428
IS 0.7000 0.7667 0.4143 0.6273 0.5800 0.5767
HIS (Imputed) 0.3854 0.3140 0.7231 0.6000 0.4434 0.5479
HIPred 0.7073 0.7333 0.5682 0.6346 0.6757 0.7024
ASD 1
EvoTol 0.4016 0.2400 0.8478 0.6316 0.5065 0.4978
GHIS 0.7429 0.8085 0.3043 0.5429 0.6087 0.5185
RVIS 0.7468 0.8077 0.3778 0.6000 0.6296 0.6925
HIS 0.3563 0.2000 0.6316 0.3333 0.4615 0.4023
IS 0.5158 0.5660 0.4043 0.5172 0.4524 0.4621
HIS (Imputed) 0.3684 0.2174 0.7442 0.4762 0.4706 0.4426
HIPred 0.6049 0.6667 0.3542 0.5079 0.5152 0.4948
ASD 2
EvoTol 0.4015 0.2931 0.7308 0.5484 0.4810 0.4428
GHIS 0.6757 0.7647 0.2245 0.5065 0.4783 0.5646
RVIS 0.6905 0.7593 0.3400 0.5541 0.5667 0.6259
HIS 0.4490 0.4130 0.7143 0.6552 0.4808 0.5609
IS 0.6275 0.6724 0.4630 0.5735 0.5682 0.5923
HIS (Imputed) 0.3750 0.2857 0.7273 0.5714 0.4444 0.5483
HIPred 0.6211 0.6667 0.4259 0.5373 0.5610 0.5640
Note: NPV, negative predictive value; AUC, area under the curve.
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3.3 Rank correlation between methods
Following the above benchmarks, we tested the correlation in gene
ranks between the methods (based on absolute Spearman’s rank cor-
relation coefficient, see Table 3). Unsurprisingly, the highest correl-
ation was observed between HIS and HIS (Imputed). Disregarding
the HIS scores, rank correlations fall in the range 0.03–0.58, with
correlations between EvoTol and all other methods being generally
low. It appears that HIPred has a moderate correlation with all
existing methods (coefficients range from 0.4994 to 0.5739, with
the exception of EvoTol which yields a correlation coefficient of
0.0478).
4 Discussion
In this study, we outlined HIPred, an integrative approach that com-
bines genomic and evolutionary features with functional annota-
tions from ENCODE and Roadmap Epigenomics to predict
haploinsufficiency. We evaluated 3 approaches for data integration:
integration at the data, kernel (MKL) and classifier (stacking) level;
and observed improved performances over existing methods using
all data integration techniques. In our experiments, we observed
that MKL and stacking classifiers outperformed classifiers con-
structed for one type of data. However, we found that the most in-
tuitive data integration technique, i.e. integration at the data level,
outperformed other (more complex) data integration techniques.
We observed comparable performances to existing methods using
SVMs on the integrated data, but improved performances using a
gradient boosted machine. The improved performance may be the
result of the implicit feature selection performed in gradient boosted
machines. Therefore, it may be possible to improve the performance
of our MKL-based classifier using feature selection before data inte-
gration. However, our stacking classifier uses random forests (which
are also tree-based methods similar to gradient boosted machines)
for most feature groups and therefore performs some form of feature
selection before data integration, so it is unclear how much benefit
MKL would gain from feature selection. One main advantage to in-
tegration at the data level is the ability to capture the potential rela-
tionships between features across feature groups (which are missed
using MKL and stacking based approaches).
We benchmarked HIPred using several datasets and have shown
that our method performs as well as, and in most cases, outperforms
existing algorithms. An important issue to consider when comparing
the performance of any prediction algorithm is the benchmark being
used. Here, it is preferable to use blind datasets, i.e. data that have
not been used to train the algorithm, to minimize any bias in the
observed performance. Although we took care to reduce this bias in
our results by performing an extensive cross-validation analysis and
excluding genes from our benchmarks that were also present in our
training data, this level of testing is not possible with alternative
methods as it would require training each method using common
data. Therefore, the performance of alternative methods may be
inflated. Furthermore, it has been shown that most biological net-
works used in existing methods are effected by study bias (Steinberg
et al., 2015), i.e. well-studied genes are over-represented in these
networks compared with less studied genes. As a result, existing al-
gorithms may not generalize well to less studied genes. For example,
the performance of most existing algorithms drops when predicting
on the MGI datasets, which comprise less studied genes. In contrast,
HIPred doesn’t appear to be affected by this study bias and outper-
forms existing methods on these datasets.
Other important factors to consider when evaluating predictive
methods are potential artifacts in performance arising due to gene
similarity. Although we did not observe any gene similarities within
our training data at the nucleotide sequence (up to 60% sequence
similarity), we did not test for potential gene similarities at the pro-
tein sequence level.
The advent of large genome sequencing consortia, such as the
1000 genomes project (The 1000 Genomes Project Consortium,
2012), NHLBI Exome Sequencing Project (ESP) and the ExAC (Lek
et al., 2016), creates an urgent need for unbiased haploinsufficiency
prediction methods such as HIPred.
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